Patent · US Active

Methods for treating heart failure by inhibiting the mitochondrial sodium-calcium exchanger (mNCE)

US8791079B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2010
Grant dateJul 29, 2014
Priority date
Expiry dateMay 18, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compounds for preventing or reducing the toxic side effects of cardiac glycosides by inhibiting the mitochondrial sodium-calcium exchanger (mNCE) are provided. Methods and compositions for preventing or reducing the occurrence of conditions associated with heart failure, including, but not limited to, sudden cardiac death and contractile decompensation, by inhibiting the mNCE also are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.